Next Article in Journal
Selective Serotonin Reuptake Inhibitors: Antimicrobial Activity Against ESKAPEE Bacteria and Mechanisms of Action
Previous Article in Journal
Silver-Treated Sutures for the Prevention of Biofilm-Associated Surgical Site Infections
Previous Article in Special Issue
Metatranscriptomic Analysis Reveals Actively Expressed Antimicrobial-Resistant Genes and Their Hosts in Hospital Wastewater
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Emergence of Carbapenem-Resistant blaPOM-1 Harboring Pseudomonas otitidis Isolated from River Water in Ghana

1
Department of Molecular Microbiology and Immunology, Institute of Science Tokyo, Tokyo 113-8510, Japan
2
Department of Parasitology and Tropical Medicine, Institute of Science Tokyo, Tokyo 113-8510, Japan
3
Computational Bio Big-Data Open Innovation Laboratory, AIST-Waseda University, Tokyo 169-0082, Japan
4
Research Organization for Nano & Life Innovation, Waseda University, Tokyo 162-8644, Japan
5
Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo 162-8640, Japan
6
Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo 162-8640, Japan
7
Department of Bacterial Pathogenesis, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
8
Department of Bacteriology, Noguchi Memorial Institute for Medical Research, Accra P.O. Box LG43, Ghana
*
Author to whom correspondence should be addressed.
Antibiotics 2025, 14(1), 50; https://doi.org/10.3390/antibiotics14010050
Submission received: 30 October 2024 / Revised: 17 December 2024 / Accepted: 1 January 2025 / Published: 8 January 2025

Abstract

:
Introduction: Pseudomonas otitidis, known for carrying the blaPOM-1 gene and linked to various diseases, is widely distributed. However, its prevalence in Ghana is unknown, mainly due to misidentification or inadequate research. In this study, for the first time, we characterized P. otitidis from Densu river water in Ghana. Methods: The antimicrobial susceptibility and whole genome characteristics of two strains (Tg_9B and BC12) were determined. The resistance and virulence features were determined using ResFinder and the VFDB database, respectively. Maximum-likelihood phylogeny was conducted based on amino acid sequences of blaPOM-1 and P. otitidis core genomes. Results: The strains carried blaPOM-1 on the chromosome, with only Tg_9B showing intermediate resistance to meropenem. Tg_9B had a unique genetic make-up downstream of blaPOM-1, compared with BC12 and other reference strains. Both strains harbored virulence factors able to induce pathogenicity through immune evasion. The efflux pump genes (adeF, rsmA, and qacG) were present in the genomes of all the strains used in this study. The amino acid sequences of POM-1 in the strains shared a sequence homology with seven other sequences from different countries. Conclusions: This study highlights the emergence of blaPOM-1 harboring P. otitidis in Ghana and affirms the conservation of blaPOM-1 and adeF, rsmA, and qacG in the species.

1. Introduction

Metallo-β-lactamases (MBL) are well known for their clinical significance in resistance determination, attributed to their potent carbapenemase activities [1]. These enzymes are classified as class B β-lactamases, which are further subdivided into three primary structural subclasses: B1, B2, and B3 [2]. Bacterial strains of clinical significance relevant to resistance determination, such as Bacillus spp., Stenotrophomonas maltophilia, Aeromonas spp., Bacteroides fragilis, Flavobacteria spp., and Pseudomonas otitidis, are infrequently intrinsically resistant to carbapenems [3,4,5].
P. otitidis is a species of Pseudomonas and was initially documented to carry an intrinsic MBL known as POM (P. otitidis MBL) in a patient diagnosed with acute otitis externa [6]. The subclass B3 MBL POM-1 enzyme demonstrates broad substrate specificity, particularly towards penicillin and carbapenems [7]. MBL-producing Pseudomonas clones have been associated with the onset of various critical illnesses, such as septicemia and pneumonia [8]. The blaPOM-1 gene harbored by P. otitidis encodes a carbapenem-hydrolyzing MBL [9] and is also reported to be associated with patients diagnosed with necrotizing fasciitis and peritonitis [10].
Determining the appropriate oral antibiotic for pneumonia and other infections caused by P. otitidis at discharge can be challenging. This was evident in a patient whose blood isolate was sensitive to piperacillin–tazobactam and gentamicin; after a 7-day treatment, they were discharged but returned a month later with bilateral pneumonia and bronchiectasis. Additionally, a P. otitidis isolate from a Japanese patient with multiple myeloma was initially treated with sulfamethoxazole 400 mg/trimethoprim 80 mg, but symptoms reappeared on the fourth day. The treatment was then switched to meropenem and later substituted with a combination of cefepime and levofloxacin. In Denmark, fluoroquinolones are considered the only effective oral antibiotics against Pseudomonas species, and it is recommended to use a combination of at least two antibiotics. Prolonged parenteral antibiotic treatment is often necessary to effectively eradicate P. otitidis. Nevertheless, reports concerning P. otitidis in Ghana were largely nonexistent until recently, when Logtong et al. documented the isolation of this species from pharmaceutical effluent [11]. However, their study did not address the genomic characteristics of the isolated strain.
The limited reporting of P. otitidis may be attributed to its misidentification as the important human pathogen Pseudomonas aeruginosa, a species recognized for its colonization capabilities, immune evasion strategies, and potential to induce lesions in human hosts [12]. This misidentification is likely to have been due to the similarities in their genotypic and phenotypic profiles, with P. otitidis sharing 84.3% of its virulence genes with P. aeruginosa. Also, PCR and MALDI-TOF/MS have been reported as reliable alternatives for bacterial identification [10]. However, many hospitals in Ghana resort to phenotypic tests due to resource limitations. This issue was confirmed in recent studies, where P. otitidis was misidentified as Pseudomonas fluorescens by the API 20E system [11]. The misidentification of pathogens can lead to significant issues, including the selection of inappropriate antibacterial therapies. This is especially critical for immunocompromised patients, who are often treated with carbapenems that are ineffective against blaPOM-1-harboring P. otitidis. Furthermore, carbapenem resistance serves as a key indicator of a bacterium’s capacity to develop further resistance. Therefore, it is imperative to monitor and understand the presence and mechanisms of carbapenem-resistant P. otitidis, as this knowledge can inform infection control practices and contribute to broader efforts aimed at combating antibiotic resistance.
P. otitidis’s presence extends beyond clinical settings, inhabiting lagoons [13], food [14], dead bodies of animals [12], activated sludge [15,16], freshwater [13,17,18], and drinking water [19]. Rivers are recognized as fundamental sources of renewable water for humans and the freshwater biosphere [20]. However, the microbial heterogeneity in flowing freshwater is often underemphasized compared with marine or lake ecosystems [21]. The structure of a river’s microbial community has been proposed as an indicator of pollution [22] and may encompass not only broad functional diversities but also multi-drug-resistant bacteria, which could pose a pathogenic risk to humans and livestock [23].
The potential increase in pathogenic bacteria in river water is a significant concern in developing countries characterized by inadequate sewage treatment, low-income levels, rapid population growth, and water stress [24]. Therefore, accumulating the antimicrobial resistance data of water-borne pathogens in aquatic environments is required in order to monitor them, particularly in resource-limited regions. This study marks the first comprehensive genomic analysis of carbapenem-resistant blaPOM-1 P. otitidis isolate collected from a river in Ghana.

2. Results

2.1. Antimicrobial Susceptibility Profiles

Tg_9B and BC12 strains isolated from different parts (Avaga and Pakro) of the Densu river (Figure 1) were identified as P. otitidis by 16S rRNA sequencing. The Tg_9B strain showed intermediate resistance to meropenem but was susceptible to all the other antimicrobials used (Table 1). However, the BC12 strain was susceptible to all the classes of antimicrobials used (Table 1). Both strains were mCIM-negative. The results were interpreted according to the CLSI 2022 guidelines [25].

2.2. Genomic Characterization, Resistome, and Virulome Analysis of P. otitidis Tg_9B and BC12 Strains

The strains contained the chromosomal blaPOM-1 gene, which was situated on a 6,050,884 bp chromosome (accession no. CP132337) in strain Tg_9B and on a 6,113,211 bp chromosome (accession no. CP102328.1) in strain BC12. Both strains also harbored the resistance–nodulation–cell division (RND) antibiotic efflux pump genes (adeF and rsmA) and the small multi-drug resistance (SMR) efflux pump gene (qacG).
Virulence factors of Tg_9B and BC12 were investigated; one hundred and sixty (160) and one hundred and sixty-five (165) virulence factors were identified via the Virulence Factor Database, respectively (Table 2). Genes encoding quorum sensing, anti-phagocytosis, protease enzyme regulation, iron uptake, efflux pump activity, endotoxin and toxin adherence, amino acid and purine metabolism, immune evasion and invasion, magnesium uptake, stress adaption, and secretion systems were detected (Table 2 and Supplementary Table S1).

2.3. Phylogenetic Relationship of POM Amino Acid Sequences and P. otitidis Core Genomes

The maximum-likelihood phylogenetic tree was constructed using POM-1 amino acid sequences from P. otitidis strains Tg_9B and BC12, in conjunction with 14 subclasses of MBL amino acid sequences (Figure 2). Notably, Tg_9B and BC12 shared a sequence homology with seven POM-1 amino acid sequences (BBT16706.1, ABY56045.1, WP069564206.1, WP140423326.1, ADC79555.1, MWK56609.1, WP330101093.1) and a POM-2 enzyme (WP140423326.1) (Figure 2). Also, another POM-1 amino acid sequence (WP069563233.1) from Pseudomonas spp. shared a close sequence homology with a PAM-1 enzyme B3 (BAO0115.1) from P. alcaligenes (Figure 2). This observation corroborates prior studies indicating that PAM-1 shares a 72.4% amino acid identity with POM-1 [26]. The POM-1 amino acid sequences from our study strains were not closely related to the other subclass B3 (L1, PAM-1, and NDM-1) (Figure 2).
A maximum-likelihood phylogenetic tree was constructed using the core genomes of two P. otitidis strains from this study and twenty-two P. otitidis strains obtained from the NCBI database. It was revealed that Tg_9B and BC12 shared a common lineage with TL17, VA161-2, BML-PP033, NK1, and 25 K strains, originating from China, Czech Republic, Japan, Malaysia, and Brazil, respectively (Figure 3). Interestingly, BC12 showed a close relationship with BML-PP033, isolated in Japan in 2019, while Tg_9B was closely associated with VA161-2 found in the Czech Republic in 2020 (Figure 3). Furthermore, all twenty-two strains included the presence of the RND efflux pump genes (adeF and rsmA) and SMD efflux pump gene, (qacG), which were also identified in Tg_9B and BC12 (Figure 3).

2.4. Genetic Environment of Tg_9B and BC12 and Their Associated Virulence Factors

Upstream of blaPOM-1, both strains exhibited the same cascade of open reading frames (Figure 4). Interestingly, downstream of blaPOM-1, strain Tg_9B showcased gene sequences of glutathione S-transferase (GST) gene, transcriptional factor (TF) gene, and araC, whereas strain BC12 only contained araC (Figure 4).
In a detailed analysis of the genetic environments of Tg_9B and BC12 in comparison to the blaPOM-1 chromosomal genomes from strains MBr4 (accession no. APO2264.1) and TL17 (accession no. CP1263421.1) retrieved from the NCBI database, a striking contrast was revealed. While MBr4 and TL17 exhibited a shared genetic arrangement with Tg_9B and BC12 upstream of blaPOM-1, the downstream sequences showcased a distinct composition of genes of phosphonate, ABC transporter permease, ATP binding protein, and ABC transporter substrate binding protein, setting them apart from Tg_9B and BC12 (Figure 4).

3. Discussion

Water, a natural habitat for Pseudomonas spp., provides a diverse environment for their adaptation and reproduction, spanning rivers, tap water, seawater, and bottled drinking water [27]. Likewise, P. otitidis has been identified in wastewater, highlighting the conservation of blaPOM-1 within the species [4]. This study focused on river water in Ghana, a vital resource for humans and livestock, and a site of recreation, particularly for children.
The blaPOM-1 gene produces an MBL that confers resistance to carbapenems. However, the gene’s resistance to carbapenem varies, mostly in the case of imipenem and meropenem. While resistant to imipenem and meropenem, it remains susceptible to piperacillin–tazobactam, ceftazidime, and aztreonam, as per CLSI or EUCAST guidelines [4]. Some strains may show sensitivity to imipenem but reduced susceptibility to meropenem, as seen in a study by Vieira et al. in 2020 [12]. This pattern was observed in one strain in the current study. While BC12 was susceptible to all antimicrobials, strain Tg_9B showed intermediate resistance to meropenem. Furthermore, a study by Wong et al. in 2015 [14] found that P. otitidis strains from food were generally sensitive to all the antimicrobials tested, except for imipenem and meropenem. Thaller et al. collected 20 strains of P. otitidis to investigate their sensitivity to metallo-β-lactams and the production of metallo-β-lactamases (MBLs). That study found that all strains exhibited sensitivity to piperacillin, cefotaxime, ceftazidime, and aztreonam, while some strains demonstrated a decrease in sensitivity to carbapenems. POM-1 has also been reported to have a higher catalytic efficiency against carbapenems compared with piperacillin, ceftazidime, or aztreonam [7]. This implies that immunocompromised patients who are typically treated with carbapenems require comprehensive investigation to ascertain that their infections are not attributable to bla-POM-1-producing P. otitidis. Both strains harbor the blaPOM-1 gene, known for its lack of hydrolyzing activity towards aztreonam, like other MBLs [28], and this was confirmed as they displayed susceptibility to aztreonam treatment. This underscores the clinical potential of aztreonam in the management of infections caused by MBL-producing bacterial pathogens [29].
The blaPOM-1 gene is conserved in P. otitidis, a species that is widely distributed and has been implicated in numerous infections. For instance, Kim et al. (2016) documented two critical cases: one involving necrotizing fasciitis and the other peritonitis [10]. In 2015, researchers isolated 10 strains identified as P. otitidis from foot cleft patients [30]. In 2020, Japanese researchers sequenced the whole genome of P. otitidis TUM18999 from burn patients [31]. In 2021, Danish physicians reported a case involving a patient with moderate chronic obstructive pulmonary disease, bronchiectasis, and recurrent pneumonia, where blood cultures demonstrated growth of P. otitidis. The study reported that this emerging pathogen poses a risk of misdiagnosis, which is concerning [32]. Furthermore, P. otitidis is prevalent in natural environments. Miyazaki et al. isolated a P. otitidis strain from Lake Biwa, Japan, and sequenced its genome [18]. Kaur et al. studied tap water from public toilets in Punjab, India, isolating 25 bacterial strains, including P. otitidis [33]. Additionally, researchers identified 13 isolates as P. otitidis from carbapenemase-producing Gram-negative bacilli in American factories and adjacent wastewater [34]. Vieira et al. isolated meropenem-insensitive P. otitidis from chicken carcasses and conducted in-depth genomic characterization [12]. Alarmingly, carbapenem-resistant P. otitidis has also been isolated from frozen food. Given these findings, it is not surprising that our maximum-likelihood phylogenetic analysis revealed that the genes from Ghana identified in our study shared sequence homology with blaPOM-1 genes identified in seven other P. otitidis strains from various countries (Figure 2). This confirms the high conservation and species-specific nature of blaPOM-1, while also indicating significant sequence variability for the POM-1 amino acid among P. otitidis strains. However, the prevalence of the blaPOM-1 gene in Ghana is currently unknown, making this study crucial for raising awareness among clinicians and microbiologists and highlighting the necessity for further research.
Virulence factors in P. aeruginosa disrupt host cell signaling pathways and target the extracellular matrix [35], contributing to various diseases by evading the host’s immune system [36]. The bacterial LPS, consisting of lipid A and O antigens [37], triggers immune responses leading to dysregulated inflammation, potentially causing morbidity and mortality [38]. P. aeruginosa’s elastase LasB destroys host tissue, crucial in burn wounds and acute lung infections [39], while alginate reduces susceptibility to phagocytosis [40]. Notably, all these virulence factors were found in both P. otitidis strains. This reflects previous reports that P. otitidis shared 83.4% of the virulence factors produced by P. aeruginosa [12]. Kim et al. highlighted P. otitidis as a potential cause of hospital-acquired infections [10]. The isolation of these strains from river water, a source of drinking water for humans and livestock, raises significant concerns and emphasizes the need for preventive measures. This result indicates that blaPOM-1-producing P. otitidis isolates, either carbapenem-resistant or -susceptible, are believed to possess the ability to actively participate in immune evasion mechanisms, potentially contributing to severe outcomes such as mortality.
The global prevalence of blaPOM-1-producing P. otitidis is well documented, but Ghana has yet to contribute to this research area. There was a report of two P. otitidis isolates harboring the blaPOM-1 gene in Nigeria [41]; however, the significance of this discovery was not extensively highlighted. To bridge this gap, we collected twenty-two P. otitidis strains from the NCBI database and integrated our two river strains from Ghana into a comprehensive maximum-likelihood phylogenetic analysis. The discovery that Tg_9B and BC12 share a common genetic ancestry with strains from China, Czechia, Japan, Malaysia, and Brazil (Figure 3) underscore the extensive distribution of P. otitidis. Given its ubiquitous nature, it is expected that more species may be present in Ghana but perhaps misidentified due to their shared genotypic and phenotypic characteristics with P. aeruginosa. The challenges in accurately identifying P. otitidis using phenotypic tests are well documented, with PCR and MALDI-TOF/MS emerging as more reliable alternatives [10]. However, it is noteworthy that many hospitals in Africa, particularly in Ghana, continue to utilize primarily phenotypic tests for identification purposes. Therefore, it is essential to consider P. otitidis when a suspected Pseudomonas species shows unique susceptibility, such as sensitivity to penicillin or cephalosporin antibiotics, but resistance to carbapenems.
The RND efflux pump superfamily, predominantly linked to intrinsic resistance in Gram-negative bacteria, is instrumental in the emergence of multi-drug resistance. P. aeruginosa is characterized by 12 distinct RND pumps that share antibiotic substrates [42]. In the context of this study, both P. otitidis strains were found to harbor the RND pump genes adeF and rsmA, as well as the SMR efflux protein gene qacG, recognized for its multidrug resistance properties. The study suggests that, along with blaPOM-1, the RND efflux pump genes (adeF and rsmA) and the SMD efflux pump gene (qacG) are essential conserved elements in P. otitidis. The presence of these genes in both strains from this study and in all twenty-two P. otitidis strains analyzed in the phylogenetic study highlights their significance and conservation within the species.
Following the divergence of P. otitidis from other species, the gene blaPOM-1 was believed to have been acquired through horizontal transfer mechanisms and integrated downstream of the conserved phosphonate operon [12]. This genetic arrangement was observed in the reference strains (MrB4 and TL17) obtained from the NCBI database (Figure 4); however, the downstream of blaPOM-1 was followed by gene sequences of GST-TF-araC and solely araC in the Tg_9B and BC12 strains, respectively (Figure 4). The protective function of GST against the toxic effects of antimicrobial agents lies in its ability to efficiently sequester antibiotics [43]. Due to the absence of GST in the BC12 strain, it can be suggested that GST might have coupled with blaPOM-1 or played a key role in the meropenem resistance conferred by the Tg_9B strain; however, the molecular mechanisms are yet unknown. Further studies are therefore needed to unravel the association between GST and blaPOM-1 in carbapenem resistance.

4. Materials and Methods

4.1. Sample Collection Site and Bacterial Isolation

A volume of 2000 mL of Densu river water was collected from Avaga (N 5°49′40″ W 0°20′3) and Pakro (N 5°54′42″ W 0°19′14) (Figure 1), near Nsawam, away from animal farms and medical facilities, in the eastern part of Ghana. The water samples were filtered sequentially using different sizes (5 µm, 0.8 µm, and 0.45 µm) of filters (Merck Mllipore Ltd., County Cork, Ireland). The filters were put in 1 mL of sterile saline, and a volume of 100 µL was enriched in 2 mL tryptic soy broth (TSB) (Oxoid Ltd., Basingstoke, UK) at 37 °C overnight. A volume of 20 µL of the bacterial cultures was spread on bromothymol blue agar (Eiken Chemical Co., LTD, Tochigi, Japan,) plates. About five to eight morphologically different colonies from each plate were further passaged onto fresh agar plates and stored in skimmed milk (Morinaga Milk, Tokyo, Japan) for further analysis.

4.2. 16 S rRNA Species Identification

Crude DNA was extracted from the isolates using a Nucleospin Tissue Kit (Macherey-Nagel, Düren, Germany) as described previously [44]. Ten (10 µL) microliters of PCR reaction mix was prepared with 5 µL of 2× Emerald premix (Takara, Japan), 0.5 µL each of forward primer 8UA (5′-AGAGTTTGATCMTGGCTCAG-3′) and reverse primer 1485B (5′-TACGGTTACCTTGTTACGAC-3′), 3 µL of nuclease-free water, and 1 µL of DNA template. The PCR was run at an initial denaturation at 98 °C for 1 min; followed by 30 cycles of 98 °C for 5 s, 57 °C for 10 s, 72 °C for 1 min, and a final extension at 72 °C for 3 min. The PCR products were purified with EXOSAP IT (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA, USA) and sequenced on a 3730xl DNA Analyzer (Thermo Fisher Scientific) with a BigDye Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific) with 100% coverage, to generate at least 1400 bp. Identification was performed via BLAST searches of the NCBI database, utilizing a threshold identity of 100% and an e-value cutoff of 0.05, in accordance with the results obtained from sequencing.

4.3. Antimicrobial Susceptibility Testing and BlaPOM-1 Genes Screening

The minimum inhibitory concentrations (MICs) of antibiotics were determined by broth micro-dilution using DP45 dry plates (Eiken Chemical Co., Tokyo, Japan) as described in the CLSI M100-S30 guidelines [25]. Isolates were further screened for carbapenemase production following the modified carbapenemase inactivation method as outlined in the CLSI guidelines.

4.4. Genome Sequencing and Analysis

For short-read sequencing, genomic DNA was extracted with a Magattract HMW DNA kit (Qiagen, Hildon, Germany) according to the manufacturer’s instructions. Libraries were prepared using Illumina DNA prep with the IDT for Illumina DNA/RNA UD Indexes and sequenced on an Illumina MiniSeq software v4.0 (Illumina Inc, San Diego, CA, USA), generating reads of length 150 bp. Short reads were assessed for quality using fastqc v0.11.9 (https://github.com/s-andrews/FastQC (accessed on 10 September 2022)). Reads were trimmed and filtered with fastp v0.23.1 (https://github.com/OpenGene/fastp (accessed on 10 September 2022)). Libraries for long-read sequencing were prepared using the native barcoding and ligation sequencing kits EXP-NB104 (Oxford Nanopore Technologies, Oxford, UK) and SQK-LSK109 (Oxford Nanopore Technologies, Oxford, UK), respectively, according to the manufacturer’s manuals. Libraries were loaded onto FLO-MIN106 R9.4.1 flow cells and sequencing was conducted on a MinION Mk 1B (Oxford Nanopore Technologies, Oxford, UK). The generated barcoded raw reads were basecalled using Guppy v1.1.4 (https://community.nanoporetech.com/protocols/Guppy-protocol/ (accessed on 15 November 2022)). Demultiplexing of reads and trimming of adapter sequences was performed using Porechop v0.2.4 [26]. Short reads with low quality (MinION Q < 10; and long reads (≤1000 bp) were filtered out with Filtlong v0.2.1 (https://github.com/rrwick/Filtlong (accessed on 15 November 2022)). Hybrid assembly of long-read and short-read sequences was carried out with Unicycler v0.4.8 [45]. Genomes were uploaded into the RAST server (https://rast.nmpdr.org/ (accessed on 22 November 2022)) for annotation. Assembled genomes were screened for acquired antimicrobial-resistance genes, sequence types (STs), and plasmid replicon types, through the web-based CGE databases ResFinder v4.6.0 (https://cge.food.dtu.dk/services/ResFinder/ (accessed on 3 may 2024)), MLST v2.0.9 (https://cge.food.dtu.dk/services/MLST/ (accessed on 15 January 2023)), and Plasmid Finder v2.0.1 (https://cge.food.dtu.dk/services/PlasmidFinder/ (accessed on 15 January 2023)), respectively. Antimicrobial-resistance genes were also identified through the web-based comprehensive antibiotic resistance database (CARD) using the resistance gene identifier RGI 6.0.3, CARD 3.3.0 (https://card.mcmaster.ca/analyze/rgi (accessed on 3 May 2024)). Virulence factors were identified using the VirulenceFinder v2.0.5 (http://www.mgc.ac.cn/cgi-bin/VFs/v5/main.cgi (accessed on 15 March 2024)). Complete genomes of the P. otitidis strains identified in this study have been deposited in NCBI under BioProject PRJNA473419. Genetic context and comparison of the identified blaPOM-1 gene structures were carried out using Easy Fig v.2.2.2.

4.5. Phylogenetic Analysis

The blaPOM-1 amino acid sequences of Tg_9B and BC12 were compared with 16 partial and full amino acid sequences that were downloaded from the NCBI database. Evolutionary analyses were conducted in MEGA v11.0 [46]. The evolutionary history was inferred by using the maximum-likelihood method and JTT matrix-based model [47] with a bootstrap of 1000 replicates [48]. To investigate the strains within a global context, a maximum-likelihood phylogenetic tree was constructed, incorporating 2 strains and 22 P. otitidis genomes obtained from the NCBI database. Pangenome analysis was conducted utilizing Roary v3.12.0 [49]. The resultant core-genome alignment file from Roary was utilized in Iqtree to generate a phylogenetic tree with 1000 bootstrapping replicates [50]. The visualization and annotation of the trees were executed using iTOLv4.0, as outlined previously [51]. The lists of reference MBL amino sequences and P. otitidis genomes are summarized in Supplementary Tables S2 and S3, respectively.

5. Conclusions

Initially acknowledged for its involvement in otic infections, P. otitidis, known for its ubiquitous nature, was identified in river water in Ghana in the present study. This marks the first documented case of carbapenem-resistant blaPOM-1-producing P. otitidis in Ghana. The challenges in accurately identifying P. otitidis using phenotypic tests, particularly in low- and middle-income countries, raise significant concerns.
The detection of blaPOM-1 in the pathogen from river water underscores the potential environmental dissemination of this MBL subclass. It is essential for clinicians and microbiologists to be cognizant of the potential of P. otitidis to cause severe infections, especially in immunocompromised hospitalized patients. Further research involving a larger number of isolates is warranted to ascertain the true prevalence of the species in Ghana and to elucidate the unknown molecular mechanisms contributing to blaPOM-1-mediated carbapenem resistance.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics14010050/s1. Table S1: Virulence profiles of P. otitidis in this study, Table S2: List of MBL amino-acid sequences downloaded from NCBI GenBank database, Table S3: List of P. otitidis genomes downloaded from GenBank Database, Table S4: Annotation statistics of BC12 and Tg_9B, Table S5: Antimicrobial resistant determinants of Tg_9B using Resfinder, Table S6: Antimicrobial resistant determinants of Tg_9B using CARD, Table S7: Antimicrobial resistant determinants of BC12 using Resfinder, Table S8: Antimicrobial resistant determinants of BC12 using CARD.

Author Contributions

Conceptualization, R.S.; data curation, Y.N., M.S. and R.S.; formal analysis, F.O.A., S.M., I.P. and Y.N.; funding acquisition, Y.N., M.Y., M.S., Y.H., T.S., T.I., A.A. and R.S.; investigation, F.O.A., S.M., I.P. and M.S.; methodology, F.O.A., S.M., I.P., T.K. and Y.O.; project administration, T.S., A.A. and R.S.; resources, A.A.; supervision, R.S.; writing—original draft, F.O.A. and R.S.; writing—review and editing, F.O.A., S.M., I.P., T.K., Y.O., Y.N., M.Y., M.S., Y.H., T.S., T.I., A.A. and R.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by grants (JP24wm0225022 to M. Yoshida; JP24fk0108665, JP24fk0108683, JP24fk0108712, JP24fk0108642, JP24wm0225029, JP24wm0225022, JP24wm0125012, and JP24gm1610003 to M. Suzuki; JP24fk0108673, JP24fk0108701, JP24wm0125007, JP24wm0225022, JP24wm0325054, JP24gm1610003, and JP24gm1610007 to Y. Hoshino) from the Japan Agency for Medical Research and Development (AMED), Japan. The study was also supported by grants from Kajima Foundation.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets presented in this study can be found in online repositories at the National Center for Biotechnology Information (NCBI) BioProject database under accession number PRJNA473419. The accession numbers for the BioSamples of Tg_9B and BC12 are SAMN36900137 and SAMN30101387, respectively.

Acknowledgments

We appreciate the support of the staff at the Department of Bacteriology, Noguchi Memorial Institute for Medical Research, Accra, Ghana.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Cornaglia, G.; Giamarellou, H.; Rossolini, G.M. Metallo-β-lactamases: A last frontier for β-lactams? Lancet Infect. Dis. 2011, 11, 381–393. [Google Scholar] [CrossRef]
  2. Bush, K.; Jacoby, G.A. Updated functional classification of β-lactamases. Antimicrob. Agents Chemother. 2010, 54, 969–976. [Google Scholar] [CrossRef] [PubMed]
  3. Walsh, T.R.; Toleman, M.A.; Poirel, L.; Nordmann, P. Metallo-β-lactamases: The quiet before the storm? Clin. Microbiol. Rev. 2005, 18, 306–325. [Google Scholar] [CrossRef]
  4. Thaller, M.C.; Borgianni, L.; Di Lallo, G.; Chong, Y.; Lee, K.; Dajcs, J.; Stroman, D.; Rossolini, G.M. Metallo-β-lactamase production by Pseudomonas otitidis: A species-related trait. Antimicrob. Agents Chemother. 2011, 55, 118–123. [Google Scholar] [CrossRef] [PubMed]
  5. Meletis, G. Carbapenem resistance: Overview of the problem and future perspectives. Ther. Adv. Infect. Dis. 2016, 3, 15–21. [Google Scholar] [CrossRef] [PubMed]
  6. Clark, L.L.; Dajcs, J.J.; McLean, C.H.; Bartell, J.G.; Stroman, D.W. Pseudomonas otitidis sp. nov., isolated from patients with otic infections. Int. J. Syst. Evol. Microbiol. 2006, 56, 709–714. [Google Scholar] [CrossRef]
  7. Borgianni, L.; De Luca, F.; Thaller, M.C.; Chong, Y.; Rossolini, G.M.; Docquier, J.-D. Biochemical characterization of the POM-1 metallo-β-lactamase from Pseudomonas otitidis. Antimicrob. Agents Chemother. 2015, 59, 1755–1758. [Google Scholar] [CrossRef] [PubMed]
  8. Wang, W.; Wang, X. Prevalence of metallo-β-lactamase genes among Pseudomonas aeruginosa isolated from various clinical samples in China. J. Lab. Med. 2020, 44, 197–203. [Google Scholar] [CrossRef]
  9. Jianfeng, G.; Mohamad, R.; Halim, M.; Mohamed, M.S. Pseudomonas otitidis: Discovery, Mechanisms and Potential Biotechnological Applications. Eur. J. Biol. 2023, 82, 224–238. [Google Scholar] [CrossRef]
  10. Kim, D.; Hong, S.K.; Seo, Y.H.; Kim, M.S.; Kim, H.S.; Yong, D.; Chong, Y. Two non-otic cases of POM-1 metallo-β-lactamase-producing Pseudomonas otitidis infection: Necrotizing fasciitis and pan-peritonitis. J. Glob. Antimicrob. Resist. 2016, 7, 157–158. [Google Scholar] [CrossRef] [PubMed]
  11. Logtong, E.G.; Zakpaa, H.D. The The Assessment of Antibiotic-Resistant Bacteria in Pharmaceutical Effluents from Major Pharmaceutical Companies in Accra, Ghana. Ghana J. Sci. Technol. Dev. 2024, 10, 50–68. [Google Scholar]
  12. Vieira, T.R.; Sambrano, G.E.; Da Silva, N.M.V.; Vasconcelos, P.C.; De Oliveira, E.F.C.; De Oliveira, C.J.B.; Cibulski, S.P.; Cardoso, M. In-depth genomic characterization of a meropenem-non-susceptible Pseudomonas otitidis strain contaminating chicken carcass. Acta Sci. Vet. 2020, 48, 1743. [Google Scholar]
  13. Rodriguez-Verdugo, A.; Souza, V.; Eguiarte, L.E.; Escalante, A.E. Diversity across seasons of culturable Pseudomonas from a desiccation lagoon in Cuatro Cienegas, Mexico. Int. J. Microbiol. 2012, 2012, 201389. [Google Scholar] [CrossRef]
  14. Wong, M.H.Y.; chi Chan, E.W.; Chen, S. Isolation of carbapenem-resistant Pseudomonas spp. from food. J. Glob. Antimicrob. Resist. 2015, 3, 109–114. [Google Scholar] [CrossRef] [PubMed]
  15. Wu, J.; Jung, B.G.; Kim, K.S.; Lee, Y.C.; Sung, N.C. Isolation and characterization of Pseudomonas otitidis WL-13 and its capacity to decolorize triphenylmethane dyes. J. Environ. Sci. 2009, 21, 960–964. [Google Scholar] [CrossRef] [PubMed]
  16. Naguib, M.M.; Khairalla, A.S.; El-Gendy, A.O.; Elkhatib, W.F. Isolation and characterization of mercury-resistant bacteria from wastewater sources in Egypt. Can. J. Microbiol. 2019, 65, 308–321. [Google Scholar] [CrossRef] [PubMed]
  17. Tacao, M.; Correia, A.; Henriques, I.S. Low prevalence of carbapenem-resistant bacteria in river water: Resistance is mostly related to intrinsic mechanisms. Microb. Drug Resist. 2015, 21, 497–506. [Google Scholar] [CrossRef]
  18. Miyazaki, K.; Hase, E.; Maruya, T. Complete genome sequence of Pseudomonas otitidis strain MrB4, isolated from Lake Biwa in Japan. Microbiol. Resour. Announc. 2020, 9, e00148-20. [Google Scholar] [CrossRef]
  19. Ali, S.; Mahmood, R.; Muneer, A.; Khalil, M.; Sheikh, N.; Tahir, H.M.; Andleeb, S.; Liaqat, I.; Ashfaq Kiani, K.; Ali, N.M.; et al. Assessment of spring water microbiology and role of Typha angustata as biosorbent. Water Environ. Res. 2019, 91, 1705–1717. [Google Scholar] [CrossRef] [PubMed]
  20. Vörösmarty, C.J.; McIntyre, P.B.; Gessner, M.O.; Dudgeon, D.; Prusevich, A.; Green, P.; Davies, P. Global threats to human water security and river biodiversity. Nature 2010, 467, 555–561. [Google Scholar] [CrossRef] [PubMed]
  21. Zinger, L.; Gobet, A.; Pommier, T. Two decades of describing the unseen majority of aquatic microbial diversity. Mol. Ecol. 2012, 21, 1878–1896. [Google Scholar] [CrossRef] [PubMed]
  22. Atlas, R.M. Diversity of microbial communities. In Advances in Microbial Ecology; Springer: Boston, MA, USA, 1984; pp. 1–47. [Google Scholar]
  23. Ibekwe, A.M.; Ma, J.; Murinda, S.E. Bacterial community composition and structure in an Urban River impacted by different pollutant sources. Sci. Total Environ. 2016, 566, 1176–1185. [Google Scholar] [CrossRef]
  24. Abraham, W.R. Megacities as sources for pathogenic bacteria in rivers and their fate downstream. Int. J. Microbiol. 2011, 2011, 798292. [Google Scholar] [CrossRef]
  25. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 30th ed.; CLSI Document M100-S30; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2020. [Google Scholar]
  26. Suzuki, M.; Suzuki, S.; Matsui, M.; Hiraki, Y.; Kawano, F.; Shibayama, K. A subclass B3 metallo-β-lactamase found in Pseudomonas alcaligenes. J. Antimicrob. Chemother. 2014, 69, 1430–1432. [Google Scholar] [CrossRef]
  27. Morris, D.O.; Davis, M.F.; Palmeiro, B.S.; O’Shea, K.; Rankin, S.C. Molecular and epidemiological characterization of canine Pseudomonas otitis using a prospective case-control study design. Vet. Dermatol. 2017, 28, 118-e25. [Google Scholar] [CrossRef]
  28. Prah, I.; Nukui, Y.; Yamaoka, S.; Saito, R. Emergence of a high-risk Klebsiella michiganensis clone disseminating carbapenemase genes. Front. Microbiol. 2022, 13, 880248. [Google Scholar] [CrossRef] [PubMed]
  29. Shibu, P.; McCuaig, F.; McCartney, A.L.; Kujawska, M.; Hall, L.J.; Hoyles, L. Improved molecular characterization of the Klebsiella oxytoca complex reveals the prevalence of the kleboxymycin biosynthetic gene cluster. Microb. Genom. 2021, 7, 000592. [Google Scholar] [CrossRef] [PubMed]
  30. Balasubramani, G.; Induja, K.; Aiswarya, D.; Deepak, P.; Arul, D.; Kavitha, M.; Perumal, P. Isolation and characterization of human foot crack–associated bacterium, Pseudomonas Otitidis, and its biological propensity. Smart Sci. 2019, 7, 79–90. [Google Scholar] [CrossRef]
  31. Yamada, K.; Aoki, K.; Nagasawa, T.; Sasaki, M.; Murakami, H.; Ishii, T.; Tateda, K. Complete whole-genome sequence of the novel Pseudomonas species strain TUM18999, isolated from a patient with a burn wound in Japan. J. Glob. Antimicrob. Resist. 2021, 24, 395–397. [Google Scholar] [CrossRef] [PubMed]
  32. Caixinha, A.L.; Valsamidis, A.N.; Chen, M.; Lindberg, M. Pseudomonas otitidis bacteraemia in a patient with COPD and recurrent pneumonia: Case report and literature review. BMC Infect. Dis. 2021, 21, 868. [Google Scholar] [CrossRef] [PubMed]
  33. Kaur, R.; Singh, D.; Kesavan, A.K.; Kaur, R. Molecular characterization and antimicrobial susceptibility of bacterial isolates present in tap water of public toilets. Int. Health 2020, 12, 472–483. [Google Scholar] [CrossRef] [PubMed]
  34. Mathys, D.A.; Mollenkopf, D.F.; Feicht, S.M.; Adams, R.J.; Albers, A.L.; Stuever, D.M.; Wittum, T.E. Carbapenemase-producing Enterobacteriaceae and Aeromonas spp. present in wastewater treatment plant effluent and nearby surface waters in the US. PLoS ONE 2019, 14, e0218650. [Google Scholar] [CrossRef] [PubMed]
  35. Rocha, A.J.; Barsottini, M.R.D.O.; Rocha, R.R.; Laurindo, M.V.; Moraes, F.L.L.D.; Rocha, S.L.D. Pseudomonas aeruginosa: Virulence factors and antibiotic resistance genes. Braz. Arch. Biol. Technol. 2019, 62, e19180503. [Google Scholar] [CrossRef]
  36. Skariyachan, S.; Sridhar, V.S.; Packirisamy, S.; Kumargowda, S.T.; Challapilli, S.B. Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal. Folia Microbiol. 2018, 63, 413–432. [Google Scholar] [CrossRef] [PubMed]
  37. Pier, G.B.; Ramphal, R. Pseudomonas aeruginosa. In Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, 6th ed.; Mandell, G.L., Bennet, J.E., Dolin, R., Eds.; Churchill Livingstone: New York, NY, USA, 2005. [Google Scholar]
  38. Mandell, G.L.; Bennett, J.E.; Dolin, R.; Schwartz, D.A. Principles and practice of infectious disease. Arch. Pathol. Lab. Med. 1997, 121, 908. [Google Scholar]
  39. Bielecki, P.; Glik, J.; Kawecki, M.; Martins dos Santos, V.A. Towards understanding Pseudomonas aeruginosa burn wound infections by profiling gene expression. Biotechnol. Lett. 2008, 30, 777–790. [Google Scholar] [CrossRef] [PubMed]
  40. Diggle, S.P.; Cornelis, P.; Williams, P.; Cámara, M. 4-quinolone signalling in Pseudomonas aeruginosa: Old molecules, new perspectives. Int. J. Med. Microbiol. 2006, 296, 83–91. [Google Scholar] [CrossRef]
  41. Le Terrier, C.; Masseron, A.; Uwaezuoke, N.S.; Edwin, C.P.; Ekuma, A.E.; Olugbeminiyi, F.; Nordmann, P. Wide spread of carbapenemase-producing bacterial isolates in a Nigerian environment. J. Glob. Antimicrob. Resist. 2020, 21, 321–323. [Google Scholar] [CrossRef]
  42. Fernando, D.M.; Kumar, A. Resistance-nodulation-division multidrug efflux pumps in gram-negative bacteria: Role in virulence. Antibiotics 2013, 2, 163–181. [Google Scholar] [CrossRef] [PubMed]
  43. Pugazhendhi, A.; Dhanarani, S.; Shankar, C.; Prakash, P.; Ranganathan, K.; Saratale, R.G.; Thamaraiselvi, K. Electrophoretic pattern of glutathione S-transferase (GST) in antibiotic resistance Gram-positive bacteria from poultry litter. Microb. Pathog. 2017, 110, 285–290. [Google Scholar] [CrossRef]
  44. Mahazu, S.; Prah, I.; Ayibieke, A.; Sato, W.; Hayashi, T.; Suzuki, T.; Saito, R. Possible Dissemination of Escherichia coli Sequence Type 410 Closely Related to B4/H24RxC in Ghana. Front. Microbiol. 2021, 12, 770130. [Google Scholar] [CrossRef]
  45. Wick, R.R.; Judd, L.M.; Gorrie, C.L.; Holt, K.E. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput. Biol. 2017, 13, e1005595. [Google Scholar] [CrossRef] [PubMed]
  46. Tamura, K.; Stecher, G.; Kumar, S. MEGA 11: Molecular Evolutionary Genetics Analysis Version 11. Mol. Biol. Evol. 2021, 38, 3022–3027. [Google Scholar] [CrossRef] [PubMed]
  47. Jones, D.T.; Taylor, W.R.; Thornton, J.M. The rapid generation of mutation data matrices from protein sequences. Comput. Appl. Biosci. 1992, 8, 275–282. [Google Scholar] [CrossRef] [PubMed]
  48. Felsenstein, J. Confidence limits on phylogenies: An approach using the bootstrap. Evolution 1985, 39, 783–791. [Google Scholar] [CrossRef]
  49. Page, A.J.; Cummins, C.A.; Hunt, M.; Wong, V.K.; Reuter, S.; Holden, M.T.; Parkhill, J. Roary: Rapid large-scale prokaryote pangenome analysis. Bioinformatics 2015, 31, 3691–3693. [Google Scholar] [CrossRef] [PubMed]
  50. Nguyen, L.T.; Schmidt, H.A.; von Haeseler, A.; Minh, B.Q. IQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 2015, 32, 268–274. [Google Scholar] [CrossRef] [PubMed]
  51. Letunic, I.; Bork, P. Interactive tree of life (iTOL) v4: Recent updates and new developments. Nucleic Acids Res. 2019, 47, W256–W259. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Graphical map of the sampling sites with a scale of 2 km. The red triangle denotes the location of Pakro Densu River, while the blue triangle indicates the position of Avaga Densu River.
Figure 1. Graphical map of the sampling sites with a scale of 2 km. The red triangle denotes the location of Pakro Densu River, while the blue triangle indicates the position of Avaga Densu River.
Antibiotics 14 00050 g001
Figure 2. Maximum-likelihood phylogenetic tree of amino acid sequences (red highlights) isolated in this study (river water = 2), and 16 reference MBL amino acids sequences (10 POM subclass B3 MBL, 4 PAM-1 subclass B3 MBL, L1 subclass B3 MBL, and NDM-1 subclass B1 MBL) deposited to the NCBI from different sources and countries.
Figure 2. Maximum-likelihood phylogenetic tree of amino acid sequences (red highlights) isolated in this study (river water = 2), and 16 reference MBL amino acids sequences (10 POM subclass B3 MBL, 4 PAM-1 subclass B3 MBL, L1 subclass B3 MBL, and NDM-1 subclass B1 MBL) deposited to the NCBI from different sources and countries.
Antibiotics 14 00050 g002
Figure 3. Maximum-likelihood phylogenetic tree based on P. otitidis core genomes. The phylogeny of Tg_9B and BC12 with respect to the other P. otitidis strains is highlighted with red-colored branches. The occurrence of AMR genes in these genomes is also illustrated, as well as the genome data (accession number, country, source, and year of collection).
Figure 3. Maximum-likelihood phylogenetic tree based on P. otitidis core genomes. The phylogeny of Tg_9B and BC12 with respect to the other P. otitidis strains is highlighted with red-colored branches. The occurrence of AMR genes in these genomes is also illustrated, as well as the genome data (accession number, country, source, and year of collection).
Antibiotics 14 00050 g003
Figure 4. Linearized comparison of the blaPOM-1 genetic environment of our study strains (Tg_9B, BC12) and strains obtained from the NCBI database (MrB4 and TL17). Similar features are represented by the same color. Gray shading indicates regions of shared homology among different elements. The darker and lighter shadings represent 100% and 67% homology, respectively.
Figure 4. Linearized comparison of the blaPOM-1 genetic environment of our study strains (Tg_9B, BC12) and strains obtained from the NCBI database (MrB4 and TL17). Similar features are represented by the same color. Gray shading indicates regions of shared homology among different elements. The darker and lighter shadings represent 100% and 67% homology, respectively.
Antibiotics 14 00050 g004
Table 1. Minimum Inhibitory Concentration (MIC) profile of P. otitidis Tg_9B and BC12.
Table 1. Minimum Inhibitory Concentration (MIC) profile of P. otitidis Tg_9B and BC12.
Antimicrobial AgentsBreakpoint for Resistance (µg/mL)Tg_9B (µg/mL)BC12 (µg/mL)
Piperacillin≥12844
Piperacilli–tazobactem≥128/44/44/4
Cefipime≥321≤0.5
Ceftazidime≥3222
Gentamicin≥16≤1≤1
Amikacin≥64≤4≤4
Levofloxacin≥42≤0.5
Aztreonam≥3248
Imipenem≥822
Meropenem≥84≤0.5
Ciprofloxacin≥2≤0.5≤0.25
Tobramycin≥16≤1≤1
Colistin≥4≤1<1
Table 2. Epidemiological Genomic data of Tg_9B and BC12.
Table 2. Epidemiological Genomic data of Tg_9B and BC12.
Virulence FactorsNumber of Related Genes
Tg_9BBC12
Adherence7779
Anti-phagocytosis2324
Enzyme22
Iron uptake1616
Protease11
Quorum sensing11
Regulation43
Secretion system2324
Toxin12
Amino acid and purine metabolism11
Efflux pump11
Endotoxin11
Glycosylation system11
Immune evasion23
Invasion22
Magnesium uptake11
Serum resistance11
Stress adaption22
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ofosu Appiah, F.; Mahazu, S.; Prah, I.; Kawamura, T.; Ota, Y.; Nishikawa, Y.; Yoshida, M.; Suzuki, M.; Hoshino, Y.; Suzuki, T.; et al. Emergence of Carbapenem-Resistant blaPOM-1 Harboring Pseudomonas otitidis Isolated from River Water in Ghana. Antibiotics 2025, 14, 50. https://doi.org/10.3390/antibiotics14010050

AMA Style

Ofosu Appiah F, Mahazu S, Prah I, Kawamura T, Ota Y, Nishikawa Y, Yoshida M, Suzuki M, Hoshino Y, Suzuki T, et al. Emergence of Carbapenem-Resistant blaPOM-1 Harboring Pseudomonas otitidis Isolated from River Water in Ghana. Antibiotics. 2025; 14(1):50. https://doi.org/10.3390/antibiotics14010050

Chicago/Turabian Style

Ofosu Appiah, Frederick, Samiratu Mahazu, Isaac Prah, Taira Kawamura, Yusuke Ota, Yohei Nishikawa, Mitsunori Yoshida, Masato Suzuki, Yoshihiko Hoshino, Toshihiko Suzuki, and et al. 2025. "Emergence of Carbapenem-Resistant blaPOM-1 Harboring Pseudomonas otitidis Isolated from River Water in Ghana" Antibiotics 14, no. 1: 50. https://doi.org/10.3390/antibiotics14010050

APA Style

Ofosu Appiah, F., Mahazu, S., Prah, I., Kawamura, T., Ota, Y., Nishikawa, Y., Yoshida, M., Suzuki, M., Hoshino, Y., Suzuki, T., Ishino, T., Ablordey, A., & Saito, R. (2025). Emergence of Carbapenem-Resistant blaPOM-1 Harboring Pseudomonas otitidis Isolated from River Water in Ghana. Antibiotics, 14(1), 50. https://doi.org/10.3390/antibiotics14010050

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop